Stay updated with breaking news from Capsulomics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Previse, formerly known as Capsulomics, Inc., announced that the company has closed a $3M seed round and launched its first...
/PRNewswire/ -- Capsulomics, Inc., a life sciences company focused on the development and commercialization of diagnostic solutions for cancer screening,...
Capsulomics Expands Leadership Team with Key Hires - read this article along with other careers information, tips and advice on BioSpace
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant sub
In a small but rigorous pilot study, Johns Hopkins Medicine researchers have shown that a novel, minimally invasive biomarker-based strategy they developed was 90% successful in detecting esophageal squamous cell carcinoma (ESCC), the predominant subtype of esophageal cancer worldwide.